Analyst Upgrades

• Abercrombie & Fitch (ANF) to positive from neutral at Susquehanna.
• tw telecom (TWTC) to outperform from neutral at Cowen.
• Agree Realty (ADC) to buy from neutral at Janney Capital.
• Millicom (MICC) to buy from neutral at Nomura.
• BioMed Realty (BMR) to outperform from market perform at FBR Capital.
• Realty Income (O) to buy from neutral at BofA/Merrill.

Huntington Bancshares (HBAN) was down 2% to $6.86 as of this writing. Earlier today, the company reported results for the fourth quarter. Should we be interested in the stock?

According to Bloomberg, net income came in at 5 cents per share. Talk about a change in fortune: last year at this time, a loss of 56 cents per share had been booked. Unfortunately, Wall Street was hoping for 8 cents per share. It should be noted, though, that the profit stat was negatively affected by 7 cents per share because management made a repayment to the United States government for use of monies involved in the Troubled Asset Relief Program (otherwise known as the famous TARP initiative).

The earnings season ramps up this week. Analysts polled by Thomson Reuters foresee strong reports from such big names as Apple (AAPL), eBay (EBAY), IBM (IBM), General Electric (GE), Google (GOOG), Schlumberger (SLB) and Southwest Airlines (LUV). And fast on the heels of last week's big earnings beat from JPMorgan Chase (JPM), there will be plenty more results from the financial sector to peruse this week.

Among the financials expected to post double-digit earnings growth this week are Capital One Financial (COF), Morgan Stanley (MS), SLM Corp. (SLM) and U.S. Bancorp (USB), but the week's biggest earnings winner may be Wells Fargo (WFC).

Analyst Upgrades

• TCF Financial (TCB) to buy from hold at Deutsche Bank.
• Exelon (EXC) to market perform from underperform at Wells Fargo.
• Nvidia (NVDA) and Boyd Gaming (BYD) upgraded to overweight from equal weight at Barclays.
• Estee Lauder (EL) to buy from neutral at UBS.
• Webster Financial (WBS) to buy from hold at Jefferies.
• Skilled Healthcare (SKH) to outperform from market perform at Morgan Keegan.
• Acorda Therapeutics (ACOR) to outperform from market perform at Leerink.
• NCR Corp. (NCR) to outperform from neutral at Wedbush.
• Barnes & Noble (BKS) to neutral from underperform and Pioneer Natural (PXD) to outperform from neutral at Credit Suisse.
• Autodesk (ADSK) to buy from neutral at Goldman.

This was one of those pre-holiday trading sessions where the closing bell outcome depended on which index you looked at. Tech stocks were up with the S&P 500, but the DJIA was a mixed bag throughout the trading day. This appears to have been a 3-year high for NASDAQ and a 2-year high for the S&P. As far as the holiday-shortened week is concerned, today may be a blueprint for trading here in the U.S. and abroad.

Here were today's unofficial closing bell levels:

Dow Jones 11,478.13 -13.78 (-0.12%)
S&P 500 1,247.08 +3.17 (0.25%)
Nasdaq 2,649.56 +6.59 (0.25%)

Top Analyst Calls

Analyst Upgrades

• InterMune (ITMN) to outperform from neutral at RW Baird.
• Huntington Bancshares (HBAN) to buy from neutral at BofA/Merill.
• Halliburton (HAL), Cloud Peak Energy (CLD), Patriot Coal (PCX) and Consol Energy (CNX) to outperform from market perform at FBR Capital.
• Post Properties (PPS) to equal weight from underweight at Barclays.
• Airgas (ARG) to overweight from neutral at Piper Jaffray.
• Hologic (HOLX) to top pick from sector perform and Sunesis Pharma (SNSS) to outperform from sector perform at RBC Capital.

Trade deficits, record government budget deficits... Humbug! Today was a day where bad news did not matter in the broader sense. Overseas markets were up, but the U.S. was where the action was.

Here were the unofficial closing bell levels:

Dow 10,896.91 +148.65 (1.38%)
S&P 500 1,171.67 +15.88 (1.37%)
Nasdaq 2,425.02 +49.71 (2.09%)

Top Analyst Calls

Here are some highlights from this past week's earnings coverage on BloggingStocks:

• Advanced Micro Devices Inc. (AMD) shares declined despite an earnings beat and a positive outlook
• Bank of America Corp. (BAC) reported that its Q4 loss widened more than expected by Wall Street.
• Capital One Financial Corp. (COF) reported better-than-expected earnings but shares declined.
• Colgate-Palmolive Co. (CL) is seen as on-track to record double-digit earnings growth in 2010.
• Cree Inc. (CREE) strong earnings and revenue growth sent shares to a new 52-week high.

Last week, JPMorgan Chase & Co. (JPM) led off the coming parade of earnings from the big banks when it reported better-than-expected fourth-quarter and full-year earnings, though its revenue fell short of estimates.

Plenty more earnings from the financial sector are due out this week. Analysts surveyed by Thomson Reuters anticipate fourth-quarter earnings growth from American Express Co. (AXP), Bank of New York Mellon Corp. (BK), Hudson City Bancorp Inc. (HCBK), SLM Corp. (SLM) and US Bancorp (USB).

Analyst upgrades:

• Kaufman Bros. upgraded American Superconductor (NASDAQ: AMSC) to Buy from Hold as it believes the follow-on contract from Sinovel has positive implications. The firm has a $36 price target on shares.
• Goldman upgraded Nike (NYSE: NKE) to Buy from Neutral citing valuation, visible long-term growth, and signs of sales stabilization. The firm has a $75 target on shares.
• Deutsche Bank upgraded Huntington Bancshares (NASDAQ: HBAN) to Buy from Hold on valuation following the recent underperformance. The firm raised its target on shares to $5.50 from $4.
• Novartis (NYSE: NVS) was upgraded to Buy from Hold at Citigroup.
• eHealth (NASDAQ: EHTH) was upgraded to Buy from Accumulate at ThinkEquity.
• China Precision Steel (NASDAQ: CPSL) was upgraded to Hold from Sell at Roth Capital.

TheStreet.com's Jim Cramer says everyone in the trenches knows we're better off now -- only the academics disagree.

Am I nuts, or am I missing something? One year after the financial system was brought to its knees, we are back in the mid-9000s and we have taken off the table massive bank risk and are well on our way to recovery.

I keep listening to people like Nobel Prize winner Joseph Stiglitz say the banking system is worse off now and I say to myself, "That's just stupid and wrong and anti-empirical and actually just silly." Anyone who knows what's really going on has to feel this way. And where was Stiglitz when some of us were running around trying to save things?

The Street.com's Jim Cramer says that now it is all about who is going to take advantage of the opportunities.

Did anyone listen to Bill Isaac yesterday? Did anyone listen to the man that was instrumental in solving the banking crisis of 1987-1991 when he was on "Squawk Box?"

I don't think they did. If they did, they wouldn't be nearly as fretful about housing or the bank stocks or the mortgage problem or the toxic bonds as they seem to be, because Isaac talked about 1,600 banks that had to be closed and about how there simply was no place to put the bad assets at all. He talked about major banks collapsing day after day after day, the largest banks in the most important regions in the country. He talked about how hardly a day went by when a bank that they were not prepared to deal with went under because of mortgage loans.

TheStreet.com's Jim Cramer says many stocks, considered frothy at one time, have turned into good turnaround stories.

Here's still one more version of a short-seller's nightmare. What happens when froth turns to investible? What happens when you see behavior that clearly indicates froth and then, somehow, the fundamentals change, and the stock takes off?

We have seen that recently in so many situations that it is pretty dazzling. It was one thing to see Genworth (NYSE: GNW) (Cramer's Take) back from the dead on its own.

Analyst upgrades:

• Jefferies upgraded VMware (NYSE: VMW) to Hold from Underperform on expectations June quarter revenue will be inline-to-slightly-better and negative revisions to September quarter revenue will not be as great as in the most recent two quarters. The firm raised its target on shares to $25 from $20.
  
• Citigroup upgraded Blue Nile (NASDAQ: NILE) to Buy from Hold on valuation following the recent pullback and believes expectations for Q2 are reasonable. The firm has a $50 price target on the stock.
  
• FBR Capital upgraded Bronco Drilling (NASDAQ: BRNC) to Market Perform from Underperform on valuation as it believes negative sentiment will ease. The firm raised its target on shares to $4 from $3.
• Unilever (NYSE: UL) was upgraded to Overweight from Neutral at JP Morgan.
  
• Posco (NYSE: PKX) was upgraded to Overweight from Equal Weight at Morgan Stanley.
  
• Gol Linhas Aereas (NYSE: GOL) was upgraded to Buy from Underperform at BofA/Merrill.

TheStreet.com's Jim Cramer says now that most banks have raised capital, maybe it'll help the FDIC dole out assets of the losers.

Can I just say that I don't care about the public-private investment program? It was a good idea before the stress tests and would have been excellent if all of these banks hadn't raised capital.

But they have.

So now we have to struggle with the notion of the program's relevance. It can be used as a cleanup program for some companies that desperately want to sell down assets to clean up their books, but with the capital raises, none of the major banks should be interested in selling into it.